Minnesota Epilepsy Group - PA — Saint Paul, Minnesota

Minnesota Epilepsy Group - PA is a clinical research site located in Saint Paul, Minnesota, United States 55102-2383.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Epilepsy Group - PA has participated in 1 clinical trials.

Therapeutic areas: Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Epilepsy Group - PA?

Minnesota Epilepsy Group - PA has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Epilepsy Group - PA conducted?

Minnesota Epilepsy Group - PA has 1 clinical trials on record. Their work covers Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma.

Is Minnesota Epilepsy Group - PA accredited by Crixeo Health?

Minnesota Epilepsy Group - PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Epilepsy Group - PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.